. 2022 Feb 7;13:778322. doi: 10.3389/fendo.2022.778322

Table 1.

Target and purpose of the nuclear medicine scans used in this report.

Target	Norepinephrine transporter	Somatostatin receptor	Glucose transporter	L amino acid transporter
Functional imaging	[¹²³I]MIBG SPECT/CT	[¹¹¹In]In-Pentetreotide/[^99mTc]Tc-HYNIC-TOC SPECT/CT, [⁶⁸Ga]Ga-DOTA-TOC PET/CT, [⁶⁸Ga]Ga-DOTA-TOC PET/MR	[¹⁸F]fludeoxyglucose PET/CT	l-6-[¹⁸F] Fluorodopa PET/CT
Purpose	Diagnostic and [¹³¹I]MIBG therapy planning	Diagnostic and [¹⁷⁷Lu] Lu-DOTA-TATE therapy planning	Diagnostic, prognostic, and metabolic.	Diagnostic and metabolic. Similarity with [^123-I]MIBG uptake
Purpose	Diagnostic and [¹³¹I]MIBG therapy planning	Diagnostic and [¹⁷⁷Lu] Lu-DOTA-TATE therapy planning	Allows to rule out radionuclide therapy